Novavax shows that the old way of creating vaccines of giving an adjuvant along with the protein (or a subunit) works fine and works with less side-effects. While Novavax does use their own patented adjuvant that needs rare ingridients other adjuvants are possible. Stoeker was likely right when he proposed to vaccinate everyone in Germany with the vaccine he used to vaccinate himself and his family.
We accept mask use based on the precautionary principle and we should have accepted Stoekers vaccine that demostrable produced antibodies on the same principle. While Stoeker only has data for side-effects for hundred patient the fact that the side effects on average are so much lower then that of viral vector and mRNA vaccines suggests that it’s likely a safer vaccine (and the fact that Novavax has less side effects supports this).
Suing Stoeker on the allegation of running an unregistered clinical trial on his family was the height of ignorance.
Focusing clinical trial resources on untested and hard to scale up vaccine technology was a very bad idea when it was easy to take existing adjuvants, synthezise the spike protein (/domains of it) and scale up the production.
Any self-respecting COVID rant must foreground vaccination. It is the solution, where other policies just buy time, or else consume old or disabled people.
This is false. Vaccines are not the only possible policy to drive COVID-19 to extinction. While we haven’t spend the amount on clinical trials that would be necessary to know for certain the best guess for the effect of prophylactic ivermectin we have at the moment is Low-certainty evidence found that ivermectin prophylaxis reduced COVID-19 infection by an average 86% (95% confidence interval 79%–91%).
The case for challenge trials for prophylactic ivermectin is the same as the case for challenge trials for vaccines.
While taking taffix multiple times per day is more annoying it also is a potential of doing the work of bringing infection risk down. It getting completely ignored instead of running more studies was a policy failure.
Several times (fomites, masks, asymptomatic spread, long COVID, schools, lab-leak) we saw dramatic reversals of global policy, based not on dramatic new evidence, but on shifts in how elite factions decided to interpret the evidence.
While it’s popular to say that the lab-leak shift wasn’t because of new evidence I think it was because people like Ian Lipkin who published in the beginning of the pandemic that he considers the natural origin the only possible explanation, because they thought that the WIV was doing gain-of-function experiements in biosafety 3 or 4 actually read the papers from the WIV and discovered that they did the experiements in biosafety 2.
While the papers certainly existed beforehand I don’t think they were in the expert awareness.
Novavax shows that the old way of creating vaccines of giving an adjuvant along with the protein (or a subunit) works fine and works with less side-effects. While Novavax does use their own patented adjuvant that needs rare ingridients other adjuvants are possible. Stoeker was likely right when he proposed to vaccinate everyone in Germany with the vaccine he used to vaccinate himself and his family.
We accept mask use based on the precautionary principle and we should have accepted Stoekers vaccine that demostrable produced antibodies on the same principle. While Stoeker only has data for side-effects for hundred patient the fact that the side effects on average are so much lower then that of viral vector and mRNA vaccines suggests that it’s likely a safer vaccine (and the fact that Novavax has less side effects supports this).
Suing Stoeker on the allegation of running an unregistered clinical trial on his family was the height of ignorance.
Focusing clinical trial resources on untested and hard to scale up vaccine technology was a very bad idea when it was easy to take existing adjuvants, synthezise the spike protein (/domains of it) and scale up the production.
This is false. Vaccines are not the only possible policy to drive COVID-19 to extinction. While we haven’t spend the amount on clinical trials that would be necessary to know for certain the best guess for the effect of prophylactic ivermectin we have at the moment is Low-certainty evidence found that ivermectin prophylaxis reduced COVID-19 infection by an average 86% (95% confidence interval 79%–91%).
The case for challenge trials for prophylactic ivermectin is the same as the case for challenge trials for vaccines.
While taking taffix multiple times per day is more annoying it also is a potential of doing the work of bringing infection risk down. It getting completely ignored instead of running more studies was a policy failure.
While it’s popular to say that the lab-leak shift wasn’t because of new evidence I think it was because people like Ian Lipkin who published in the beginning of the pandemic that he considers the natural origin the only possible explanation, because they thought that the WIV was doing gain-of-function experiements in biosafety 3 or 4 actually read the papers from the WIV and discovered that they did the experiements in biosafety 2.
While the papers certainly existed beforehand I don’t think they were in the expert awareness.